Conditions: T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Keywords: omega-3 carboxylic acid
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 223
Healthy volunteers: no

Brief summary:
This study is a double-blind randomized, placebo-controlled, parallel-group, 12 week study performed in up to 5 centres in Sweden to assess the effect of Omega-3 carboxylic acids and dapagliflozin on liver fat in patients with Type 2 diabetes with fatty liver (\>5.5% as measured with magnetic resonance imaging (MRI))

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: placebo intervention 2: Omega-3 carboxylic acids intervention 3: Dapagliflozin intervention 4: Placebo
Intervention descriptions: intervention 1: Placebo matching to Omega-3 carboxylic acids (olive oil) intervention 2: 4 g administered as 4 x 1 g capsules intervention 3: 10 mg administered as 10 mg tablet intervention 4: Placebo matching to dapagliflozin 10 mg

Protocol document: